SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-23-044530
Filing Date
2023-05-31
Accepted
2023-05-31 17:20:06
Documents
5
Period of Report
2023-07-13

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea179423-def14a_oramed.htm DEF 14A 389629
2 GRAPHIC image_001.jpg GRAPHIC 29481
3 GRAPHIC image_002.jpg GRAPHIC 28918
4 GRAPHIC proxy_001.jpg GRAPHIC 784759
5 GRAPHIC proxy_002.jpg GRAPHIC 262939
  Complete submission text file 0001213900-23-044530.txt   1914496
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35813 | Film No.: 23982088
SIC: 2834 Pharmaceutical Preparations